Drug Database
N04 ANTI-PARKINSON DRUGS
Approved by UK Medicines & Healthcare Products Regulatory Agency & the European Medicines Agency.
- N04AA01 trihexyphenidyl
- N04AA04 procyclidine
- N04AB02 orphenadrine (chloride)
- N04BA02 levodopa and decarboxylase inhibitor
- N04BA03 levodopa, decarboxylase inhibitor and COMT inhibitor
- N04BA07 foslevodopa and decarboxylase inhibitor
- N04BB01 amantadine
- N04BC04 ropinirole
- N04BC05 pramipexole
- N04BC06 cabergoline
- N04BC07 apomorphine
- N04BC09 rotigotine
- N04BD01 selegiline
- N04BD02 rasagiline
- N04BD03 safinamide
- N04BX01 tolcapone
- N04BX02 entacapone
- N04BX04 opicapone
Learning Zones
Disclaimer
The drug SPC information (indications, contra-indications, interactions, etc), has been developed in collaboration with eMC (www.medicines.org.uk/emc/). Medthority offers the whole library of SPC documents from eMC.
Medthority will not be held liable for explicit or implicit errors, or missing data.
Drug Licencing
Drugs appearing in this section are approved by UK Medicines & Healthcare Products Regulatory Agency (MHRA), & the European Medicines Agency (EMA).